FAMILIAL HEMIPLEGIC MIGRAINE-1

Clinical trials for FAMILIAL HEMIPLEGIC MIGRAINE-1 explained in plain language.

Never miss a new study

Get alerted when new FAMILIAL HEMIPLEGIC MIGRAINE-1 trials appear

Sign up with your email to follow new studies for FAMILIAL HEMIPLEGIC MIGRAINE-1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Hope for rare brain disease: Final-Stage trial tests promising pill

Disease control Not yet recruiting

This study is testing if a medication called N-Acetyl-L-Leucine can help control symptoms and improve daily life for people with rare, inherited disorders caused by a faulty CACNA1A gene. These disorders affect coordination, balance, and speech. In this final-stage trial, 60 part…

Matched conditions: FAMILIAL HEMIPLEGIC MIGRAINE-1

Phase: PHASE3 • Sponsor: IntraBio Inc • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

FAMILIAL HEMIPLEGIC MIGRAINE-1

Get alerted when new FAMILIAL HEMIPLEGIC MIGRAINE-1 trials appear

Hope for rare brain disease: Final-Stage trial tests promising pill